Myriad Price, News and Analysis (XMY)

Sign in or create an account to add this currency to your watchlist.
Myriad logo
$0.00
+$0.00 (+0.73%)
(As of 07/16/2018 04:45 AM ET)
1-Hour Price Change +2.57%
1-Day Price Change +0.73%
7-Day Price Change -10.42%
1-Day Volume$18,247.00
Market Cap$5.47 million
BTC Price0.00000054 BTC
Circulating Supply1.59 billion
Total Supply1.59 billion
Maximum SupplyN/A

About Myriad (XMY)

Currency Details

Name Myriad
SymbolXMY
Market Capitalization$5.47 million
Coin or TokenCoin
AlgorithmMultiple
Proof TypePoW
Genesis Date2/23/2014
Mineable?No
Number of Exchanges3

Official Links

Official Websitemyriadcoin.org
Official Website (Alt)N/A
BitcoinTalk AnnouncementView
Twitter Account@myriadcoin
Facebook PageN/A
Github AccountView

Community Discussion

Reddit Communityr/myriadcoin
Telegram GroupView
Discord GroupView
Message BoardN/A
Message Board (Alt)N/A

Research Tools

Blockchain Explorercryptap.us
Blockchain Explorer (Alt)insight-myr.cryptap.us
CoinMarketCapView
CryptoCompareView
CoinGeckoView

Receive XMY News and Prices via Email

Sign-up to receive the latest news and price data for Myriad and its competitors with MarketBeat's CryptoBeat newsletter.
The Truth About Cryptocurrencies

Myriad (XMY) Frequently Asked Questions

What exchanges can I buy or trade Myriad on?

Myriad can be purchased or sold on the following cryptocurrency exchanges: Bittrex, LiteBit.eu and Cryptopia.

How do I buy Myriad?

It is not possible to buy most cryptocurrencies with U.S. dollars. Bitcoin, Bitcoin Cash, Ethereum and Litecoin can be purchased with U.S. dollars using Coinbase. Once you have purchased Bitcoin using Coinbase, you can then transfer your Bitcoin to an exchange such as Binance or Changelly to purchase other cryptocurrencies, including Myriad.

Where can I get Myriad wallet?

Myriad produces its own wallet software that is available for download on its website, which allows you to store Myriad on your computer. For maximum security, you can store your cryptocurrencies on a dedicated hardware wallet such as a TREZOR wallet or a Ledger Nano S. If you do not wish to buy a hardware wallet, you may consider using a mobile wallet such as Jaxx or Coinomi to store multiple cryptocurrencies with some added security benefits.

What is the value of Myriad?

One Myriad (XMY) is currently worth $0.00 on major cryptocurrency exchanges. You can also exchange one Myriad for 0.00000054 bitcoin(s) on major exchanges. The value (or market capitalization) of all available Myriad in U.S. dollars is $5.47 million.

What hashing algorithm does Myriad use?

Myriad is a proof of work (PoW) coin that uses the Multiple algorithm.

How do I mine Myriad?

Myriad can be mined using specialized mining software. XMR Stak is a commonly-used mining tool that works for CPU mining and GPU mining with both Nvidia and AMD graphics cards. CCMiner is another popular mining tool for computers with NVIDIA graphics cards. In addition to having mining software, you will need a Myriad and access to a mining pool that pools your effort with other miners and a wallet to store the Myriad that you earn from mining. Most cryptocurrencies have multiple publicly-available mining pools that can be found with a simple Google search.

What coins are similar to Myriad?

The following coins use the same hashing algorithm (Multiple) as Myriad: DigiByte, Primecoin, Circuits of Value, Quark, HunterCoin, Joincoin and BitQuark.

What is the Reddit page for Myriad?

The official Reddit community (subreddit) for Myriad is r/myriadcoin.


MarketBeat Community Rating for Myriad (XMY)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  101 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  163
MarketBeat's community ratings are surveys of what our community members think about Myriad and other cryptocurrencies. Vote "Outperform" if you believe the stock will outperform other cryptocurrencies over the long term. Vote "Underperform" if you believe the stock will underperform other cryptocurrencies over the long term. You may vote once every thirty days.

Chart

Myriad (XMY) Price Chart for Monday, July, 16, 2018

Loading chart…

Google Trends

Myriad (XMY) Search Trends

There is a correlation between price appreciation and public interest in cryptocurrencies, such as Myriad. Many cryptocurrency investors use Google Trends, which measures the volume of web searches for a particular topic over time, as a tool to gauge whether public interest is increasing or decreasing for a particular cryptocurrency. The chart below shows how search volume has changed for the phrase "Myriad Coin" over the last 90 days.



Myriad (XMY) Website Traffic




Myriad (XMY) Social Media Trends

Headlines

Myriad (XMY) News Headlines

DateHeadline
Why Myriad Genetics, Activision Blizzard, and Cars.com Jumped TodayWhy Myriad Genetics, Activision Blizzard, and Cars.com Jumped Today
www.fool.com - July 11 at 6:08 PM
MYRIAD GENETICS 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Myriad Genetics, Inc.MYRIAD GENETICS 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Myriad Genetics, Inc.
markets.financialcontent.com - June 18 at 11:51 PM
DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Myriad Genetics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018 – MYGNDEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Myriad Genetics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018 – MYGN
markets.financialcontent.com - June 18 at 7:39 PM
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Actions Involving Myriad Genetics, Inc., Allegiant Travel Company, Aceto Corporation, and Gridsum Holding Inc.SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Actions Involving Myriad Genetics, Inc., Allegiant Travel Company, Aceto Corporation, and Gridsum Holding Inc.
markets.financialcontent.com - June 17 at 10:16 AM
FINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact The FirmFINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact The Firm
feeds.benzinga.com - June 12 at 11:49 PM
FINAL DEADLINE NOTICE: Kaskela Law LLC Alerts Myriad Genetics, Inc. Investors of Class Action Lawsuit and Important June 19, 2018 DeadlineFINAL DEADLINE NOTICE: Kaskela Law LLC Alerts Myriad Genetics, Inc. Investors of Class Action Lawsuit and Important June 19, 2018 Deadline
markets.financialcontent.com - June 12 at 11:16 AM
MYGN Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Myriad Genetics, Inc. InvestorsMYGN Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Myriad Genetics, Inc. Investors
markets.financialcontent.com - June 8 at 9:19 PM
Heres Why Myriad Genetics Stock Gained 29.1% in MayHere's Why Myriad Genetics Stock Gained 29.1% in May
www.fool.com - June 8 at 9:52 AM
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Fir
markets.financialcontent.com - June 6 at 1:52 PM
Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc.Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc.
feeds.benzinga.com - June 4 at 7:01 PM
Myriad Genetics Presents Second Pivotal Validation Study for riskScore™ Test at the 2018 American Society of Clinical Oncology (ASCO) Annual MeetingMyriad Genetics Presents Second Pivotal Validation Study for riskScore™ Test at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
feeds.benzinga.com - June 1 at 7:33 AM
Myriad Genetics to acquire Counsyl for $375M in cash and stockMyriad Genetics to acquire Counsyl for $375M in cash and stock
seekingalpha.com - May 29 at 8:12 AM
Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc.Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc.
feeds.benzinga.com - May 28 at 7:48 PM
MYGN ALERT: Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Deadline in Class Action - MYGNMYGN ALERT: Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Deadline in Class Action - MYGN
www.prnewswire.com - May 19 at 11:48 AM
MYRIAD GENETICS SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGNMYRIAD GENETICS SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN
www.prnewswire.com - May 18 at 11:42 PM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Myriad Genetics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018 – MYGNEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Myriad Genetics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018 – MYGN
markets.financialcontent.com - May 18 at 3:20 PM
Better Buy: Opko Health, Inc. (OPK) vs. Myriad Genetics (MYGN)Better Buy: Opko Health, Inc. (OPK) vs. Myriad Genetics (MYGN)
www.fool.com - May 18 at 2:40 PM
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. (MYGN) and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. (MYGN) and Encourages Investors to Contact the Firm
markets.financialcontent.com - May 14 at 3:13 PM
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact Brower Piven Before The Lead Plaintiff DeaSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact Brower Piven Before The Lead Plaintiff Dea
markets.financialcontent.com - May 13 at 11:09 PM
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action LawsuitSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
feeds.benzinga.com - May 13 at 11:09 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – MYGNSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – MYGN
feeds.benzinga.com - May 12 at 9:25 AM
Robbins Geller Rudman & Dowd LLP Announces a Securities Case Has Been Filed on Behalf of Purchasers of Myriad Genetics, Inc. StockRobbins Geller Rudman & Dowd LLP Announces a Securities Case Has Been Filed on Behalf of Purchasers of Myriad Genetics, Inc. Stock
markets.financialcontent.com - May 11 at 9:52 PM
MYGN INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Myriad Genetics, Inc. and a Lead Plaintiff Deadline of June 19, 2018MYGN INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Myriad Genetics, Inc. and a Lead Plaintiff Deadline of June 19, 2018
markets.financialcontent.com - May 6 at 5:23 PM
Kaskela Law LLC: Shareholder Class Action Filed Against Myriad Genetics, Inc. - MYGNKaskela Law LLC: Shareholder Class Action Filed Against Myriad Genetics, Inc. - MYGN
feeds.benzinga.com - May 6 at 1:13 PM
Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian CancerMyriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer
markets.financialcontent.com - May 4 at 7:30 AM
Myriad Lawsuit: Bernstein Liebhard LLP Reminds Investors of Important Deadline in Class Action Against Myriad Genetics, Inc. - MYGNMyriad Lawsuit: Bernstein Liebhard LLP Reminds Investors of Important Deadline in Class Action Against Myriad Genetics, Inc. - MYGN
feeds.benzinga.com - May 3 at 3:49 PM
MYGN LOSS NOTICE: Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Deadline in Class Action – MYGNMYGN LOSS NOTICE: Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Deadline in Class Action – MYGN
markets.financialcontent.com - April 29 at 9:13 AM
RM LAW Announces Class Action Lawsuit Against Myriad Genetics, Inc.RM LAW Announces Class Action Lawsuit Against Myriad Genetics, Inc.
www.prnewswire.com - April 27 at 8:13 PM
Robbins Arroyo LLP: Myriad Genetics, Inc. (MYGN) Misled Shareholders According to a Recently Filed Class ActionRobbins Arroyo LLP: Myriad Genetics, Inc. (MYGN) Misled Shareholders According to a Recently Filed Class Action
markets.financialcontent.com - April 25 at 8:31 PM
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact Brower Piven Before The Lead Plaintiff DeadlineSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact Brower Piven Before The Lead Plaintiff Deadline
feeds.benzinga.com - April 23 at 11:00 PM
MYRIAD GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit AgMYRIAD GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Ag
markets.financialcontent.com - April 23 at 3:28 PM
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Myriad Genetics, Inc.SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Myriad Genetics, Inc.
markets.financialcontent.com - April 23 at 1:34 PM
Pomerantz Law Firm Announces the Filing of a Class Action against Myriad Genetics, Inc. and Certain Officers – MYGNPomerantz Law Firm Announces the Filing of a Class Action against Myriad Genetics, Inc. and Certain Officers – MYGN
feeds.benzinga.com - April 20 at 10:09 PM
Global Genetic Testing Market 2018-2022 - Key Vendors are Abbott, bioMrieux, Bio-Rad Laboratories, F. Hoffmann-La Roche, Myriad Genetics, QIAGEN & Quest DiagnosticsGlobal Genetic Testing Market 2018-2022 - Key Vendors are Abbott, bioMrieux, Bio-Rad Laboratories, F. Hoffmann-La Roche, Myriad Genetics, QIAGEN & Quest Diagnostics
www.prnewswire.com - April 6 at 3:48 PM
MYRIAD GENETICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Myriad Genetics, Inc. To Contact The FirmMYRIAD GENETICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Myriad Genetics, Inc. To Contact The Firm
www.prnewswire.com - March 19 at 8:19 PM
Bragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. (MYGN) on Behalf of Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. (MYGN) on Behalf of Stockholders and Encourages Investors to Contact the Firm
markets.financialcontent.com - March 19 at 12:01 PM
MYGN INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Myriad Genetics, Inc. InvestorsMYGN INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Myriad Genetics, Inc. Investors
markets.financialcontent.com - March 16 at 7:34 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors Myriad Genetics, Inc.SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors Myriad Genetics, Inc.
markets.financialcontent.com - March 16 at 11:22 AM
Myriad Genetics -6% after disclosing U.S. government billing probeMyriad Genetics -6% after disclosing U.S. government billing probe
seekingalpha.com - March 12 at 5:51 PM
Myriad Genetics Demonstrates Strong Commitment to Preventing Hereditary Colon Cancer as Part of National Colorectal Cancer Awareness MonthMyriad Genetics Demonstrates Strong Commitment to Preventing Hereditary Colon Cancer as Part of National Colorectal Cancer Awareness Month
markets.financialcontent.com - March 1 at 7:10 AM
A Preview Of Myriad Genetics Q2 EarningsA Preview Of Myriad Genetics' Q2 Earnings
feeds.benzinga.com - February 6 at 1:04 PM
LYNPARZA® (olaparib) Approved by US FDA in Germline BRCA-Mutated Metastatic Breast CancerLYNPARZA® (olaparib) Approved by US FDA in Germline BRCA-Mutated Metastatic Breast Cancer
markets.financialcontent.com - January 12 at 2:40 PM

Social Media Mentions

Myriad (XMY) Reddit Feed


This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.